| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Myriad Genetics, Inc. (MYGN) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. MYGN is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.07M | $4.81M | - | |
| Other | 573.4K | $2.58M | - | |
| COO | 381.8K | $1.72M | - | |
| Other | 251.9K | $1.13M | - | |
| Other | 170.2K | $765.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2015 | King Gary A. | Exec. VP International Ops | Sale+OE | 10,000 | $42.82 | $428,200.00 | -11.0% | |
| Oct 28, 2015 | Lanchbury Jerry S81 | Chief Scientific Officer | Sale+OE | 50,962 | $41.86 | $2,133,269.32 | -41.9% | |
| Oct 27, 2015 | Lanchbury Jerry S81 | Chief Scientific Officer | Sale+OE | 24,767 | $41.80 | $1,035,260.60 | -8.0% | |
| Sep 17, 2015 | Lanchbury Jerry S81 | Chief Scientific Officer | Sale+OE | 60,270 | $39.89 | $2,403,921.30 | -21.1% | |
| Sep 16, 2015 | Marsh Richard M | E.v.p., General Counsel | Sale+OE | 35,000 | $41.25 | $1,443,750.00 | -32.0% | |
| Sep 14, 2015 | King Gary A. | Exec. VP International Ops | Sale+OE | 14,562 | $39.41 | $573,888.42 | -22.1% | |
| Sep 3, 2015 | King Gary A. | Exec. VP International Ops | Sale+OE | 25,438 | $39.41 | $1,002,511.58 | -33.1% | |
| Sep 2, 2015 | King Gary A. | Exec. VP International Ops | Sale+OE | 15,000 | $38.23 | $573,450.00 | -22.6% | |
| Aug 28, 2015 | King Gary A. | Exec. VP International Ops | Sale+OE | 30,000 | $35.73 | $1,071,900.00 | -36.8% |